NUTX · Nutex Health Inc. · Earnings Call Transcripts & Audio
Market Cap
$1.37B
Shares
6.85M
Nutex Health Inc. Earnings Call Transcripts
Quarterly earnings calls for Nutex Health Inc. (NUTX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲19.7%
$67.45M
−$364,000
'24 Q1
24-05-09
▲29.1%
$76.08M
−$364,000
'24 Q2
24-08-08
▲25.6%
$78.80M
−$8.79M
'24 Q3
24-11-07
▲269.8%
$257.62M
$61.70M
'24 Q4
25-03-31
▲214%
$211.79M
$21.22M
'25 Q1
25-05-13
▲220.7%
$243.99M
−$17.70M
'25 Q2
25-08-14
▼41.1%
$151.68M
$11.83M
'25 Q4
26-03-06
▲2.2%
$216.49M
$46.81M
'26 Q1
26-05-01
LATEST
▼13.6%
$210.75M
$65.84M
'26 Q2
26-08-07
Earnings call
FY26 · Q2
2026-08-07
Nutex Health Inc. (NUTX) Q2 2026 Earnings Call
Revenue
$210.75M
▼ 13.6% YoY Diluted EPS
$9.38
Gross margin
67.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-01
Nutex Health Inc. (NUTX) Q1 2026 Earnings Call Transcript
Confident tone
IPA / Population Health segment
IDR / payer reimbursement and No Surprises Act
Revenue and earnings performance
Revenue
$216.49M
▲ 2.2% YoY Diluted EPS
$6.52
▲ 95.8% YoY Gross margin
42.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-06
Nutex Health Inc. (NUTX) Q4 2025 Earnings Call Transcript
Confident tone
IDR arbitration and No Surprises Act
Hospital expansion pipeline
Revenue and earnings growth
Revenue
$151.68M*
▼ 41.1% YoY Gross margin
30.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q2
2025-08-14
Nutex Health Inc. (NUTX) Q2 2025 Earnings Call Transcript
Confident tone
No Surprises Act / IDR Arbitration Strategy
Financial Performance and Growth
Mature Hospital Performance and Patient Acuity
Revenue
$243.99M
▲ 220.7% YoY Diluted EPS
$-2.95
Gross margin
51.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Nutex Health Inc. (NUTX) Q1 2025 Earnings Call Transcript
Confident tone
Balance sheet and capital allocation
Patient volume and acuity mix
Arbitration process and IDR revenue
Revenue
$211.79M
▲ 214% YoY Diluted EPS
$3.33
Gross margin
55.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-31
Nutex Health Inc. (NUTX) Q4 2024 Earnings Call Transcript
Confident tone
Arbitration / IDR process success
No Surprises Act challenges
Revenue and EBITDA growth
Revenue
$257.62M
▲ 269.8% YoY Diluted EPS
$11.12
Gross margin
55.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Nutex Health Inc. (NUTX) Q3 2024 Earnings Call Transcript
Confident tone
Revenue and patient volume growth
De novo hospital expansion pipeline
No Surprises Act and IDR reimbursement
Revenue
$78.80M
▲ 25.6% YoY Diluted EPS
$-1.72
Gross margin
27.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Nutex Health Inc. (NUTX) Q2 2024 Earnings Call Transcript
Confident tone
Population Health / IPAs
Micro-Hospital Business Model
No Surprises Act Arbitration
Revenue
$76.08M
▲ 29.1% YoY Diluted EPS
$-0.07
Gross margin
29.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
Nutex Health Inc. (NUTX) Q1 2024 Earnings Call Transcript
Confident tone
No Surprises Act Collections & Reimbursement
Population Health / Medicare Advantage (MA) Lives
Earnings Growth & Financial Performance
Revenue
$67.45M
▲ 19.7% YoY Diluted EPS
$-0.08
Gross margin
15.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–9 of 9 earnings calls